Business
Director/PDMR Dealing
Director/PDMR Dealing.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 9108H\n Renalytix PLC\n 06 August 2021\n \n \n \n \n Renalytix plc\n \n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n \n Director/PDMR Dealing\n \n \n \n \n \n \n New York, 6 August 2021\n \n - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling, the Company's Chief Financial Officer, of 12,000 American Depositary Shares (\"ADS\"), each representing two ordinary shares of £0.0025 each in the capital of the Company (\"Ordinary Shares\"), under a Rule 10b5-1 trading plan established in accordance with Rule 10b5-1 under the U.S. Securities Exchange Act of 1934, as amended, and the EU Market Abuse Regulation as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (\"MAR\").\n \n \n \n \n \n Rule 10b5-1 plans permit directors, officers and other company insiders to adopt, at times when they are not in possession of material, non-public information, or inside information, written plans for trading securities in a non-discretionary, pre-scheduled manner in the future.\n \n \n \n \n \n Following completion of the sale, O. James Sterling is interested in 1,835,236 Ordinary Shares representing 2.54% of the current issued share capital of the Company.\n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n Renalytix plc \n \n \n \n \n \n \n \n www.renalytix.com\n \n \n \n \n \n \n \n \n \n James McCullough, CEO \n \n \n \n \n \n Via Walbrook PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser, Joint Broker)\n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n \n Alex Price / Nicholas Moore \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n \n Gary Clarence / Daniel Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n Tel: 020 7933 8780 \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n Paul McManus / Lianne Cawthorne\n \n \n \n \n \n Mob: 07980 541...